138 related articles for article (PubMed ID: 9593595)
1. Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart.
Yue TL; Ma XL; Gu JL; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1998 Mar; 345(1):61-5. PubMed ID: 9593595
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.
Yue TL; Ma XL; Wang X; Romanic AM; Liu GL; Louden C; Gu JL; Kumar S; Poste G; Ruffolo RR; Feuerstein GZ
Circ Res; 1998 Feb; 82(2):166-74. PubMed ID: 9468187
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury.
Khandoudi N; Percevault-Albadine J; Bril A
J Cardiovasc Pharmacol; 1998 Sep; 32(3):443-51. PubMed ID: 9733358
[TBL] [Abstract][Full Text] [Related]
4. Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.
Feuerstein G; Liu GL; Yue TL; Cheng HY; Hieble JP; Arch JR; Ruffolo RR; Ma XL
Eur J Pharmacol; 1998 Jun; 351(3):341-50. PubMed ID: 9721026
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.
Gao F; Chen J; Lopez BL; Christopher TA; Gu J; Lysko P; Ruffolo RR; Ohlstein EH; Ma XL; Yue TL
Eur J Pharmacol; 2000 Oct; 406(1):109-16. PubMed ID: 11011041
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits.
Ma XL; Yue TL; Lopez BL; Barone FC; Christopher TA; Ruffolo RR; Feuerstein GZ
J Pharmacol Exp Ther; 1996 Apr; 277(1):128-36. PubMed ID: 8613909
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H; Minamino T; Sanada S; Takashima S; Ogita H; Ogai A; Asakura M; Liao Y; Asano Y; Shintani Y; Kim J; Shinozaki Y; Mori H; Node K; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Jun; 109(22):2773-9. PubMed ID: 15148268
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
10. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
11. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of mast cell modulators in ischemia-reperfusion-induced injury in rats.
Jaggi AS; Singh M; Sharma A; Singh D; Singh N
Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):593-600. PubMed ID: 18193110
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.
Ma XL; Kumar S; Gao F; Louden CS; Lopez BL; Christopher TA; Wang C; Lee JC; Feuerstein GZ; Yue TL
Circulation; 1999 Apr; 99(13):1685-91. PubMed ID: 10190877
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury.
Brunvand H; Frłyland L; Hexeberg E; Rynning SE; Berge RK; Grong K
Eur J Pharmacol; 1996 Oct; 314(1-2):99-107. PubMed ID: 8957224
[TBL] [Abstract][Full Text] [Related]
16. Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats.
Harima M; Arumugam S; Wen J; Pitchaimani V; Karuppagounder V; Afrin MR; Sreedhar R; Miyashita S; Nomoto M; Ueno K; Nakamura M; Watanabe K
Exp Mol Pathol; 2015 Jun; 98(3):558-62. PubMed ID: 25872160
[TBL] [Abstract][Full Text] [Related]
17. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.
Brunvand H; Liu G; Ma XL; Yue TL; Ruffolo RR; Feuerstein GZ
Eur J Pharmacol; 1998 Sep; 356(2-3):193-8. PubMed ID: 9774249
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol.
Oikawa M; Yaoita H; Watanabe K; Maruyama Y
Circ J; 2008 Dec; 72(12):2081-6. PubMed ID: 18946174
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol treatment after myocardial infarct decreases cardiomyocytic apoptosis in the peri-infarct zone during cardioplegia-induced cardiac arrest.
Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
Shock; 2013 Apr; 39(4):343-52. PubMed ID: 23481492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
